(ESAB) ESAB - Ratings and Ratios
Electrodes,Wires,Fluxes,Automated
ESAB EPS (Earnings per Share)
ESAB Revenue
Description: ESAB ESAB
ESAB Corporation is a leading global supplier of welding consumables and equipment, offering a comprehensive range of products for various industries, including general industry, infrastructure, and energy. The companys product portfolio includes electrodes, wires, fluxes, and cutting consumables, as well as software and digital solutions to enhance customer productivity.
With a strong presence in multiple regions, including North America, Europe, and Asia Pacific, ESAB Corporation has established a diverse customer base across various end-markets. The companys sales strategy involves a combination of independent distributors and direct salespeople, allowing for effective market coverage.
From a financial perspective, ESAB Corporation has demonstrated a solid performance, with a Return on Equity (ROE) of 15.08%. To further evaluate the companys financial health, we can examine additional Key Performance Indicators (KPIs) such as Revenue Growth, Gross Margin, and Debt-to-Equity ratio. For instance, a high Gross Margin could indicate the companys ability to maintain pricing power, while a low Debt-to-Equity ratio may suggest a healthy capital structure.
To gain a deeper understanding of ESAB Corporations valuation, we can analyze metrics such as the Price-to-Sales (P/S) ratio and Enterprise Value-to-EBITDA (EV/EBITDA) ratio. These metrics can provide insights into the companys relative valuation compared to its industry peers. For example, a P/S ratio of 2.5x and an EV/EBITDA ratio of 15x could indicate whether the stock is undervalued or overvalued relative to its industry.
ESAB Stock Overview
| Market Cap in USD | 6,973m |
| Sub-Industry | Industrial Machinery & Supplies & Components |
| IPO / Inception | 2022-04-05 |
ESAB Stock Ratings
| Growth Rating | 61.9% |
| Fundamental | 72.0% |
| Dividend Rating | 57.9% |
| Return 12m vs S&P 500 | -8.97% |
| Analyst Rating | 3.91 of 5 |
ESAB Dividends
| Dividend Yield 12m | 0.38% |
| Yield on Cost 5y | 0.89% |
| Annual Growth 5y | 25.99% |
| Payout Consistency | 100.0% |
| Payout Ratio | 6.6% |
ESAB Growth Ratios
| Growth Correlation 3m | -55.9% |
| Growth Correlation 12m | 12.5% |
| Growth Correlation 5y | 95.1% |
| CAGR 5y | 43.02% |
| CAGR/Max DD 3y | 1.91 |
| CAGR/Mean DD 3y | 8.65 |
| Sharpe Ratio 12m | -0.78 |
| Alpha | 0.14 |
| Beta | 0.459 |
| Volatility | 33.25% |
| Current Volume | 455.3k |
| Average Volume 20d | 442.2k |
| Stop Loss | 105.3 (-3.2%) |
| Signal | 0.11 |
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (256.2m TTM) > 0 and > 6% of Revenue (6% = 164.3m TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA -1.98pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 23.74% (prev 20.29%; Δ 3.45pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 310.0m > Net Income 256.2m (YES >=105%, WARN >=100%) |
| Net Debt (908.6m) to EBITDA (507.1m) ratio: 1.79 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.95 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (61.4m) change vs 12m ago 0.46% (target <= -2.0% for YES) |
| Gross Margin 37.75% (prev 36.23%; Δ 1.52pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 65.19% (prev 69.75%; Δ -4.56pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 6.31 (EBITDA TTM 507.1m / Interest Expense TTM 69.6m) >= 6 (WARN >= 3) |
Altman Z'' 2.27
| (A) 0.15 = (Total Current Assets 1.34b - Total Current Liabilities 686.5m) / Total Assets 4.43b |
| (B) 0.16 = Retained Earnings (Balance) 720.5m / Total Assets 4.43b |
| (C) 0.10 = EBIT TTM 439.5m / Avg Total Assets 4.20b |
| (D) 0.07 = Book Value of Equity 170.8m / Total Liabilities 2.32b |
| Total Rating: 2.27 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 72.00
| 1. Piotroski 6.0pt = 1.0 |
| 2. FCF Yield 3.30% = 1.65 |
| 3. FCF Margin 9.43% = 2.36 |
| 4. Debt/Equity 0.53 = 2.36 |
| 5. Debt/Ebitda 2.17 = -0.34 |
| 6. ROIC - WACC (= 4.83)% = 6.03 |
| 7. RoE 13.51% = 1.13 |
| 8. Rev. Trend 44.77% = 3.36 |
| 9. EPS Trend 88.94% = 4.45 |
What is the price of ESAB shares?
Over the past week, the price has changed by -4.51%, over one month by -1.30%, over three months by -11.99% and over the past year by +8.08%.
Is ESAB a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ESAB is around 115.15 USD . This means that ESAB is currently overvalued and has a potential downside of 5.82%.
Is ESAB a buy, sell or hold?
- Strong Buy: 5
- Buy: 2
- Hold: 3
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the ESAB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 133.7 | 22.8% |
| Analysts Target Price | 133.7 | 22.8% |
| ValueRay Target Price | 126.4 | 16.1% |
Last update: 2025-09-04 04:37
ESAB Fundamental Data Overview
CCE Cash And Equivalents = 258.2m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 25.1379
P/E Forward = 19.1571
P/S = 2.547
P/B = 3.3692
P/EG = 1.5837
Beta = 1.236
Revenue TTM = 2.74b USD
EBIT TTM = 439.5m USD
EBITDA TTM = 507.1m USD
Long Term Debt = 1.06b USD (from longTermDebt, last quarter)
Short Term Debt = 42.6m USD (from shortTermDebt, last quarter)
Debt = 1.10b USD (Calculated: Short Term 42.6m + Long Term 1.06b)
Net Debt = 908.6m USD (from netDebt column, last quarter)
Enterprise Value = 7.82b USD (6.97b + Debt 1.10b - CCE 258.2m)
Interest Coverage Ratio = 6.31 (Ebit TTM 439.5m / Interest Expense TTM 69.6m)
FCF Yield = 3.30% (FCF TTM 258.1m / Enterprise Value 7.82b)
FCF Margin = 9.43% (FCF TTM 258.1m / Revenue TTM 2.74b)
Net Margin = 9.36% (Net Income TTM 256.2m / Revenue TTM 2.74b)
Gross Margin = 37.75% ((Revenue TTM 2.74b - Cost of Revenue TTM 1.70b) / Revenue TTM)
Tobins Q-Ratio = 45.76 (Enterprise Value 7.82b / Book Value Of Equity 170.8m)
Interest Expense / Debt = 1.91% (Interest Expense 21.0m / Debt 1.10b)
Taxrate = 20.88% (77.3m / 370.4m)
NOPAT = 347.7m (EBIT 439.5m * (1 - 20.88%))
Current Ratio = 1.95 (Total Current Assets 1.34b / Total Current Liabilities 686.5m)
Debt / Equity = 0.53 (Debt 1.10b / last Quarter total Stockholder Equity 2.07b)
Debt / EBITDA = 2.17 (Net Debt 908.6m / EBITDA 507.1m)
Debt / FCF = 4.27 (Debt 1.10b / FCF TTM 258.1m)
Total Stockholder Equity = 1.90b (last 4 quarters mean)
RoA = 5.78% (Net Income 256.2m, Total Assets 4.43b )
RoE = 13.51% (Net Income TTM 256.2m / Total Stockholder Equity 1.90b)
RoCE = 14.87% (Ebit 439.5m / (Equity 1.90b + L.T.Debt 1.06b))
RoIC = 11.69% (NOPAT 347.7m / Invested Capital 2.97b)
WACC = 6.86% (E(6.97b)/V(8.07b) * Re(7.71%)) + (D(1.10b)/V(8.07b) * Rd(1.91%) * (1-Tc(0.21)))
Shares Correlation 3-Years: 59.54 | Cagr: 0.19%
Discount Rate = 7.71% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 80.97% ; FCFE base≈278.7m ; Y1≈332.7m ; Y5≈525.9m
Fair Price DCF = 148.2 (DCF Value 8.99b / Shares Outstanding 60.7m; 5y FCF grow 20.64% → 3.0% )
EPS Correlation: 88.94 | EPS CAGR: 15.27% | SUE: 0.42 | # QB: 0
Revenue Correlation: 44.77 | Revenue CAGR: 5.34% | SUE: N/A | # QB: None
Additional Sources for ESAB Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle